nodes	percent_of_prediction	percent_of_DWPC	metapath
Carprofen—PTGS2—Crohn's disease	0.345	1	CbGaD
Carprofen—PTGS2—Balsalazide—Crohn's disease	0.153	0.241	CbGbCtD
Carprofen—PTGS1—Balsalazide—Crohn's disease	0.129	0.204	CbGbCtD
Carprofen—PTGS2—Mesalazine—Crohn's disease	0.122	0.193	CbGbCtD
Carprofen—PTGS1—Mesalazine—Crohn's disease	0.103	0.163	CbGbCtD
Carprofen—PTGS2—Sulfasalazine—Crohn's disease	0.0684	0.108	CbGbCtD
Carprofen—PTGS1—Sulfasalazine—Crohn's disease	0.0578	0.091	CbGbCtD
Carprofen—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00175	0.107	CbGpPWpGaD
Carprofen—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00175	0.107	CbGpPWpGaD
Carprofen—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX4—Crohn's disease	0.00152	0.0931	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CREM—Crohn's disease	0.000696	0.0425	CbGpPWpGaD
Carprofen—Ketoprofen—CXCL8—Crohn's disease	0.000639	0.165	CrCbGaD
Carprofen—Ibuprofen—CXCL8—Crohn's disease	0.000629	0.163	CrCbGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IKZF1—Crohn's disease	0.000492	0.0301	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CREM—Crohn's disease	0.00045	0.0275	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000377	0.0231	CbGpPWpGaD
Carprofen—Suprofen—PTGS2—Crohn's disease	0.000367	0.0948	CrCbGaD
Carprofen—PTGS1—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000352	0.0215	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000351	0.0214	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000351	0.0214	CbGpPWpGaD
Carprofen—Fenoprofen—PTGS2—Crohn's disease	0.000316	0.0817	CrCbGaD
Carprofen—PTGS1—Overview of nanoparticle effects—CRP—Crohn's disease	0.000306	0.0187	CbGpPWpGaD
Carprofen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—Crohn's disease	0.000299	0.0183	CbGpPWpGaD
Carprofen—Naproxen—PTGS2—Crohn's disease	0.000288	0.0744	CrCbGaD
Carprofen—Fenoprofen—ALB—Crohn's disease	0.000281	0.0728	CrCbGaD
Carprofen—PTGS2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000279	0.0171	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL3—Crohn's disease	0.000262	0.016	CbGpPWpGaD
Carprofen—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—Crohn's disease	0.000262	0.016	CbGpPWpGaD
Carprofen—Naproxen—ALB—Crohn's disease	0.000256	0.0663	CrCbGaD
Carprofen—PTGS2—Overview of nanoparticle effects—CRP—Crohn's disease	0.000243	0.0148	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000224	0.0137	CbGpPWpGaD
Carprofen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000218	0.0133	CbGpPWpGaD
Carprofen—Flurbiprofen—PTGS2—Crohn's disease	0.000206	0.0533	CrCbGaD
Carprofen—PTGS1—Overview of nanoparticle effects—PTGS2—Crohn's disease	0.000205	0.0125	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000199	0.0122	CbGpPWpGaD
Carprofen—Ketoprofen—PTGS2—Crohn's disease	0.000186	0.0482	CrCbGaD
Carprofen—Flurbiprofen—ALB—Crohn's disease	0.000184	0.0475	CrCbGaD
Carprofen—Ibuprofen—PTGS2—Crohn's disease	0.000184	0.0475	CrCbGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—Crohn's disease	0.000184	0.0112	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—GPX4—Crohn's disease	0.000178	0.0109	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—MPO—Crohn's disease	0.000171	0.0104	CbGpPWpGaD
Carprofen—PTGS1—Eicosanoid Synthesis—PTGS2—Crohn's disease	0.00017	0.0104	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL3—Crohn's disease	0.000169	0.0104	CbGpPWpGaD
Carprofen—Ketoprofen—ALB—Crohn's disease	0.000166	0.043	CrCbGaD
Carprofen—Ibuprofen—ALB—Crohn's disease	0.000164	0.0423	CrCbGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000159	0.00974	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000159	0.00974	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—CXCL8—Crohn's disease	0.000158	0.00965	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000143	0.00875	CbGpPWpGaD
Carprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—Crohn's disease	0.000142	0.0087	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—MPO—Crohn's disease	0.000141	0.00859	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—TNF—Crohn's disease	0.000138	0.00846	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—MPO—Crohn's disease	0.000135	0.00828	CbGpPWpGaD
Carprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—Crohn's disease	0.000121	0.0074	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—Crohn's disease	0.000119	0.00726	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000112	0.00686	CbGpPWpGaD
Carprofen—PTGS1—Overview of nanoparticle effects—IL6—Crohn's disease	0.000112	0.00683	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—TNF—Crohn's disease	0.00011	0.00672	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—TAB1—Crohn's disease	0.000106	0.00647	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	9.92e-05	0.00606	CbGpPWpGaD
Carprofen—PTGS1—Arachidonic acid metabolism—PTGS2—Crohn's disease	9.46e-05	0.00578	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—CRP—Crohn's disease	8.97e-05	0.00548	CbGpPWpGaD
Carprofen—PTGS2—Overview of nanoparticle effects—IL6—Crohn's disease	8.87e-05	0.00542	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—ICAM1—Crohn's disease	8.25e-05	0.00504	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.1e-05	0.00495	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	8.09e-05	0.00495	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	8.09e-05	0.00495	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—Crohn's disease	7.83e-05	0.00479	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Crohn's disease	7.28e-05	0.00445	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—CRP—Crohn's disease	7.12e-05	0.00435	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	6.89e-05	0.00421	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—ALB—Crohn's disease	6.88e-05	0.0042	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—ICAM1—Crohn's disease	6.55e-05	0.004	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.43e-05	0.00393	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IFNG—Crohn's disease	6.28e-05	0.00384	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—PTGS2—Crohn's disease	6.02e-05	0.00368	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	5.8e-05	0.00354	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—GCKR—Crohn's disease	5.7e-05	0.00349	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IL1B—Crohn's disease	5.6e-05	0.00342	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.47e-05	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—ALB—Crohn's disease	5.46e-05	0.00334	CbGpPWpGaD
Carprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.42e-05	0.00331	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TLR4—Crohn's disease	5.4e-05	0.0033	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.37e-05	0.00328	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—ICAM1—Crohn's disease	5.18e-05	0.00317	CbGpPWpGaD
Carprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Crohn's disease	5.07e-05	0.0031	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	5.04e-05	0.00308	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.03e-05	0.00307	CbGpPWpGaD
Carprofen—PTGS2—C-MYB transcription factor network—CD4—Crohn's disease	4.99e-05	0.00305	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IFNG—Crohn's disease	4.98e-05	0.00305	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IL1B—Crohn's disease	4.44e-05	0.00272	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.26e-05	0.0026	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—TNF—Crohn's disease	4.06e-05	0.00248	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	3.99e-05	0.00244	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IFNG—Crohn's disease	3.94e-05	0.00241	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—CXCL8—Crohn's disease	3.66e-05	0.00224	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PLA2G4F—Crohn's disease	3.61e-05	0.00221	CbGpPWpGaD
Carprofen—SLC22A6—SLC-mediated transmembrane transport—ALB—Crohn's disease	3.57e-05	0.00218	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL1B—Crohn's disease	3.51e-05	0.00215	CbGpPWpGaD
Carprofen—PTGS1—Selenium Micronutrient Network—IL6—Crohn's disease	3.28e-05	0.002	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—TNF—Crohn's disease	3.22e-05	0.00197	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—MTMR3—Crohn's disease	3.07e-05	0.00188	CbGpPWpGaD
Carprofen—PTGS2—Disease—RSPO3—Crohn's disease	2.99e-05	0.00183	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—PLA2G4F—Crohn's disease	2.86e-05	0.00175	CbGpPWpGaD
Carprofen—PTGS2—Disease—SEL1L—Crohn's disease	2.83e-05	0.00173	CbGpPWpGaD
Carprofen—PTGS2—Selenium Micronutrient Network—IL6—Crohn's disease	2.6e-05	0.00159	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—TNF—Crohn's disease	2.55e-05	0.00156	CbGpPWpGaD
Carprofen—PTGS2—Disease—LTF—Crohn's disease	2.54e-05	0.00155	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—MTMR3—Crohn's disease	2.44e-05	0.00149	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—FADS1—Crohn's disease	2.39e-05	0.00146	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GPX4—Crohn's disease	2.24e-05	0.00137	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—GCKR—Crohn's disease	2.16e-05	0.00132	CbGpPWpGaD
Carprofen—PTGS2—Spinal Cord Injury—IL6—Crohn's disease	2.06e-05	0.00126	CbGpPWpGaD
Carprofen—PTGS2—Disease—GCKR—Crohn's disease	2.05e-05	0.00125	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—FADS1—Crohn's disease	1.9e-05	0.00116	CbGpPWpGaD
Carprofen—SLC22A6—Transmembrane transport of small molecules—ALB—Crohn's disease	1.82e-05	0.00111	CbGpPWpGaD
Carprofen—PTGS2—Disease—SLC11A1—Crohn's disease	1.81e-05	0.00111	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GPX4—Crohn's disease	1.78e-05	0.00109	CbGpPWpGaD
Carprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	1.73e-05	0.00106	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—GCKR—Crohn's disease	1.72e-05	0.00105	CbGpPWpGaD
Carprofen—PTGS2—Disease—RBX1—Crohn's disease	1.55e-05	0.000949	CbGpPWpGaD
Carprofen—PTGS2—Disease—HSPA1B—Crohn's disease	1.55e-05	0.000949	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.55e-05	0.000944	CbGpPWpGaD
Carprofen—PTGS2—Disease—UBE2D1—Crohn's disease	1.36e-05	0.000832	CbGpPWpGaD
Carprofen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.35e-05	0.000826	CbGpPWpGaD
Carprofen—PTGS2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.23e-05	0.00075	CbGpPWpGaD
Carprofen—PTGS2—Disease—SMAD3—Crohn's disease	9.74e-06	0.000596	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—ALB—Crohn's disease	6.88e-06	0.000421	CbGpPWpGaD
Carprofen—PTGS2—Disease—TYK2—Crohn's disease	6.36e-06	0.000389	CbGpPWpGaD
Carprofen—PTGS2—Disease—JAK2—Crohn's disease	6.06e-06	0.000371	CbGpPWpGaD
Carprofen—PTGS1—Metabolism—PTGS2—Crohn's disease	6.02e-06	0.000368	CbGpPWpGaD
Carprofen—PTGS2—Disease—CD4—Crohn's disease	5.75e-06	0.000351	CbGpPWpGaD
Carprofen—PTGS2—Metabolism—ALB—Crohn's disease	5.46e-06	0.000334	CbGpPWpGaD
Carprofen—PTGS2—Disease—STAT3—Crohn's disease	4.45e-06	0.000272	CbGpPWpGaD
Carprofen—PTGS2—Disease—IL6—Crohn's disease	3.11e-06	0.00019	CbGpPWpGaD
